ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Historical Holders from Q2 2018 to Q3 2025

Symbol
ONCY on Nasdaq
Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,820,198
Holdings value
$3,771,684
% of all portfolios
0%
Number of holders
56
Number of buys
18
Number of sells
-15
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 7% -26% $10,708,670 -$751,370 7,649,050 -6.6% Anson Funds Management LP 30 Sep 2025

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2,820,198 $3,771,684 +$1,889,818 $1.4 56
2025 Q2 1,495,731 $1,150,336 +$116,133 $0.773 54
2025 Q1 1,364,360 $748,757 -$5,861 $0.55 50
2024 Q4 1,314,892 $1,206,107 +$64,784 $0.9138 46
2024 Q3 999,534 $872,336 -$113,469 $0.871 40
2024 Q2 1,309,286 $1,297,302 -$118,709 $0.99 41
2024 Q1 1,409,004 $1,495,371 -$5,110,399 $1.06 35
2023 Q4 5,144,044 $6,944,143 -$1,456,985 $1.35 42
2023 Q3 6,216,229 $13,562,379 +$11,870,396 $2.18 32
2023 Q2 800,773 $2,085,599 -$679,945 $2.6 28
2023 Q1 1,103,514 $1,325,529 +$296,418 $1.2 30
2022 Q4 902,111 $1,482,300 +$321,702 $1.63 33
2022 Q3 714,327 $883,809 -$184,426 $1.23 28
2022 Q2 909,878 $911,763 +$188,561 $1 33
2022 Q1 697,567 $1,099,375 -$760,113 $1.58 29
2021 Q4 1,187,087 $1,652,710 +$287,570 $1.4 34
2021 Q3 903,524 $1,890,946 -$125,314 $2.09 32
2021 Q2 887,682 $2,434,336 -$773,341 $2.77 35
2021 Q1 1,038,987 $3,786,537 +$314,929 $3.81 36
2020 Q4 1,085,633 $2,586,529 +$776,286 $2.38 30
2020 Q3 776,299 $1,313,572 -$60,476 $1.69 27
2020 Q2 828,293 $1,562,243 +$487,963 $1.88 30
2020 Q1 590,438 $816,220 +$77,206 $1.39 28
2019 Q4 384,390 $1,816,270 +$231,441 $4.75 23
2019 Q3 391,100 $223,581 -$568,195 $0.5828 12
2019 Q2 573,234 $975,780 +$645,305 $1.7 13
2019 Q1 193,664 $358,834 +$66,521 $1.87 17
2018 Q4 156,055 $282,469 -$180,670 $1.78 15
2018 Q3 184,782 $699,979 -$1,552,787 $3.83 16
2018 Q2 586,197 $3,220,392 +$3,220,392 $5.43 18